We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current GBCMY market cap is 86.81M. The company's latest EPS is HKD and P/E is N/A.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HKD (元) | HKD (元) | HKD (元) | HKD (元) | HKD (元) | |
| Total Revenue | 4.56B | 848.87M | 746.55M | 372.28M | 1.81B |
| Operating Income | -550.56M | -1.27B | -973.74M | -842.98M | -665.3M |
| Net Income | -1.07B | -2.43B | -400.8M | -1.44B | 4.22B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HKD (元) | HKD (元) | HKD (元) | HKD (元) | HKD (元) | |
| Total Assets | 8.23B | 7.6B | 6.48B | 5.85B | 5.21B |
| Total Liabilities | 12.58B | 13.62B | 13.18B | 13.64B | 9.25B |
| Total Equity | -4.35B | -6.02B | -6.7B | -7.79B | -4.04B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HKD (元) | HKD (元) | HKD (元) | HKD (元) | HKD (元) | |
| Operating | 211.32M | -26.19M | -475.21M | -88.01M | -50.46M |
| Investing | -52.47M | 120.1M | 392.59M | -413k | -14.37M |
| Financing | -263.14M | -25.87M | -48.66M | 109.75M | 112.62M |
| Market Cap | 86.81M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 178.15M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -49.24% |
| 52 Week High | 0.96 |
| 52 Week Low | 0.3894 |
| Spread (Intraday) | 267.2k (100%) |
| Company Name | Global Bio Chem Technology Group Company Ltd (PK) |
| Address |
cricket square grand cayman KY1-1111 |
| Website | https://www.globalbiochem.com |
| Industry | food preparations, nec (2099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
